Skip to main content
. 2024 Mar 19;16(3):1933–1946. doi: 10.21037/jtd-23-1669

Table 4. Pathologic characteristics of LT patients following TS.

Characteristic Total SCC ADC SCLC Scar tissuea
Subjects 7 (100.0) 4 (57.1) 1 (14.3) 1 (14.3) 1 (14.3)
Site of TS
   Native 4 (57.1) 2 (IPF) 1 (COPD) 1 (IPF) 0
   Transplant 3 (42.9) 2 (COPD) 0 0 1 (IPF)
Type of resection
   Pneumonectomy 3 (42.9) 2 (IPF) 0 1 0
   Lobectomy 0 0 0 0 0
   Segmentectomy 2 (28.6) 2 (COPD) 0 0 0
   Non-anatomic 2 (28.6) 0 1 0 1
Pathologic TNM stage
   IA 2 (28.6) 1 0 1 0
   IIB 1 (14.3) 1 0 0 0
   IIIB 1 (14.3) 1 0 0 0
   IVA 2 (28.6) 1 1 0 0
Survival
   In-hospital 5 (71.4) 4 0 1 0
   1-year 3 (42.9) 2 1 0 0

All lung resections to evaluate lung cancer were performed using thoracotomy. Data are shown as numbers with percentages. Lung diseases for which LT was performed are shown in parenthesis. Percentages may not add up to 100% due to rounding. a, pulmonary infarction probably due to pulmonary embolism. LT, lung transplantation; TS, thoracic surgery; SCC, squamous cell cancer; ADC, adenocarcinoma; SCLC, small cell lung cancer; IPF, idiopathic pulmonary fibrosis; COPD, chronic obstructive pulmonary disease.